EU agency recommends limiting calcitonin medicines (Reuters, 20 July 2012)

24 Jul 2012


The European Medicines Agency (EMA) has updated its guidance on medicines containing calcitonin following a review of the benefits and risks.

Full article

EMA website


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story